UBS Upgrades Enhabit Home Health & Hospice (EHAB) to Neutral on Better Than Anticipated Report
Tweet Send to a Friend
UBS analyst AJ Rice upgraded Enhabit Home Health & Hospice (NYSE: EHAB) from Sell to Neutral with a price target ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
